Zurueck zur Suche

Reporte zur Charge UJ581AAA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 1 MD 1

VAERS 2483763

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ581AAA

gering
Staat
NY
Alter
0,5
Geschlecht
F
Eingang
20.10.2022
Impfdatum
12.10.2022
Beginn
12.10.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

ACTHIB was given today with the sterile diluent from the box that expired on 17SEP2022 with no adverse event.; Initial information received on 12-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 6 months old female patient to whom HIB (PRP/T) VACCINE [ACT-HIB] was given today with the sterile diluent from the box that expired on 17-Sep-2022 with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, HEPATITIS B VACCINE RHBSAG (YEAST), PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (PEDIARIX) for Immunisation; ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ) for Immunisation; and PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Immunisation. On 12-Oct-2022, the patient received today 0.5 ml dose 3 of suspect HIB (PRP/T) VACCINE, Powder and solvent for solution for injection (lot UJ581AAA; Expiration: 17-SEP-2022) via intramuscular route in the left thigh for Immunization with the sterile diluent from the box that expired on 17-Sep-2022 with no adverse event (expired product administered). Action taken : not applicable. Outcome : Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PEDIARIX; ROTATEQ; PREVNAR 13
Allergien
-
Vorherige Impfungen
-

VAERS 2372137

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ581AAA

gering
Staat
MD
Alter
-
Geschlecht
F
Eingang
18.07.2022
Impfdatum
01.06.2022
Beginn
01.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error Wrong product administered

Symptomtext

received a pediatric vaccine with no reported adverse event; Initial information received on 13-Jul-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves a 25 years old female patient who received a pediatric vaccine with no reported adverse event , and it involved vaccine HIB (PRP/T) VACCINE [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 01-Jun-2022, the patient received a 0.5 ml dose of suspect HIB (PRP/T) VACCINE, once, ( lot: UJ581AAA ; expiry date: 17-Sep-2022) via intramuscular route in unknown administration site for immunization. It was reported that patient was supposed to receive TD from Sanofi but her medical record stated that she received Tetanus IG TG. However, doctor office stated that they had no Tetanus IGTG and the patient received pediatric vaccine instead (wrong product administered) (onset date: 01-Jun-022; latency: same day). Action taken : not applicable. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-